Effects of a ß-blocker on the cardiovascular response to MDMA (Ecstasy)

Autor: Hysek CM, Vollenweider FX, Liechti ME

Publikováno v: Emergency Medicine Journal (EMJ); Aug2010, Vol. 27 Issue 8, p586-589, 4p

CYP2D6 function moderates the pharmacokinetics and pharmacodynamics of 3,4-methylene-dioxymethamphetamine in a controlled study in healthy individuals.

Autor: Schmid Y; aDivision of Clinical Pharmacology and Toxicology, Departments of Biomedicine and Clinical Research, University Hospital Basel bDepartment of Pharmaceutical Sciences, University of Basel, Basel, Switzerland., Vizeli P, Hysek CM, Prestin K, Meyer Zu Schwabedissen HE, Liechti ME

Publikováno v: Pharmacogenetics and genomics [Pharmacogenet Genomics] 2016 Aug; Vol. 26 (8), pp. 397-401.

Evaluation of drug incorporation into hair segments and nails by enantiomeric analysis following controlled single MDMA intakes.

Autor: Madry MM; Zurich Institute of Forensic Medicine, Center for Forensic Hairanalytics, University of Zurich, Winterthurerstrasse 190, 8057, Zurich, Switzerland., Steuer AE; Zurich Institute of Forensic Medicine, Forensic Pharmacology and Toxicology, University of Zurich, Winterthurerstrasse 190/52, 8057, Zurich, Switzerland., Hysek CM; Psychopharmacology Research, Division of Clinical Pharmacology and Toxicology, Department of Biomedicine and Department of Clinical Research, University Hospital Basel, Hebelstrasse 2, 4031, Basel, Switzerland., Liechti ME; Psychopharmacology Research, Division of Clinical Pharmacology and Toxicology, Department of Biomedicine and Department of Clinical Research, University Hospital Basel, Hebelstrasse 2, 4031, Basel, Switzerland., Baumgartner MR; Zurich Institute of Forensic Medicine, Center for Forensic Hairanalytics, University of Zurich, Winterthurerstrasse 190, 8057, Zurich, Switzerland., Kraemer T; Zurich Institute of Forensic Medicine, Forensic Pharmacology and Toxicology, University of Zurich, Winterthurerstrasse 190/52, 8057, Zurich, Switzerland. thomas.kraemer@irm.uzh.ch.

Publikováno v: Analytical and bioanalytical chemistry [Anal Bioanal Chem] 2016 Jan; Vol. 408 (2), pp. 545-56. Date of Electronic Publication: 2015 Oct 31.

Interactions between bupropion and 3,4-methylenedioxymethamphetamine in healthy subjects.

Autor: Schmid Y; Division of Clinical Pharmacology and Toxicology, Department of Biomedicine and Department of Clinical Research, University Hospital Basel, Basel, Switzerland (Y.S., A.R., A.S., U.D., C.M.H., M.E.L.); and Biomedicine Service, University Hospital Lausanne, Lausanne, Switzerland (E.G.)., Rickli A; Division of Clinical Pharmacology and Toxicology, Department of Biomedicine and Department of Clinical Research, University Hospital Basel, Basel, Switzerland (Y.S., A.R., A.S., U.D., C.M.H., M.E.L.); and Biomedicine Service, University Hospital Lausanne, Lausanne, Switzerland (E.G.)., Schaffner A; Division of Clinical Pharmacology and Toxicology, Department of Biomedicine and Department of Clinical Research, University Hospital Basel, Basel, Switzerland (Y.S., A.R., A.S., U.D., C.M.H., M.E.L.); and Biomedicine Service, University Hospital Lausanne, Lausanne, Switzerland (E.G.)., Duthaler U; Division of Clinical Pharmacology and Toxicology, Department of Biomedicine and Department of Clinical Research, University Hospital Basel, Basel, Switzerland (Y.S., A.R., A.S., U.D., C.M.H., M.E.L.); and Biomedicine Service, University Hospital Lausanne, Lausanne, Switzerland (E.G.)., Grouzmann E; Division of Clinical Pharmacology and Toxicology, Department of Biomedicine and Department of Clinical Research, University Hospital Basel, Basel, Switzerland (Y.S., A.R., A.S., U.D., C.M.H., M.E.L.); and Biomedicine Service, University Hospital Lausanne, Lausanne, Switzerland (E.G.)., Hysek CM; Division of Clinical Pharmacology and Toxicology, Department of Biomedicine and Department of Clinical Research, University Hospital Basel, Basel, Switzerland (Y.S., A.R., A.S., U.D., C.M.H., M.E.L.); and Biomedicine Service, University Hospital Lausanne, Lausanne, Switzerland (E.G.)., Liechti ME; Division of Clinical Pharmacology and Toxicology, Department of Biomedicine and Department of Clinical Research, University Hospital Basel, Basel, Switzerland (Y.S., A.R., A.S., U.D., C.M.H., M.E.L.); and Biomedicine Service, University Hospital Lausanne, Lausanne, Switzerland (E.G.) matthias.liechti@usb.ch.

Publikováno v: The Journal of pharmacology and experimental therapeutics [J Pharmacol Exp Ther] 2015 Apr; Vol. 353 (1), pp. 102-11. Date of Electronic Publication: 2015 Feb 05.

MDMA enhances emotional empathy and prosocial behavior.

Autor: Hysek CM; Psychopharmacology Research Group, Division of Clinical Pharmacology and Toxicology, Department of Biomedicine and Department of Internal Medicine, University Hospital and University of Basel, 4031 Basel, Switzerland, Laboratory for Biological and Personality Psychology, Department of Psychology, University of Freiburg, 79085 Freiburg, Germany, Department of Psychology, Behavioral and Clinical Neuroscience Institute, University of Cambridge, CB21TN Cambridge, UK, Social, Cognitive and Affective Neuroscience Unit, Faculty of Psychology, University of Vienna, 1010 Vienna, Austria, and Experimental and Clinical Pharmacopsychology, Department of Psychiatry, Psychotherapy and Psychosomatics, University Hospital of Psychiatry Zurich, 8032 Zurich, Switzerland., Schmid Y; Psychopharmacology Research Group, Division of Clinical Pharmacology and Toxicology, Department of Biomedicine and Department of Internal Medicine, University Hospital and University of Basel, 4031 Basel, Switzerland, Laboratory for Biological and Personality Psychology, Department of Psychology, University of Freiburg, 79085 Freiburg, Germany, Department of Psychology, Behavioral and Clinical Neuroscience Institute, University of Cambridge, CB21TN Cambridge, UK, Social, Cognitive and Affective Neuroscience Unit, Faculty of Psychology, University of Vienna, 1010 Vienna, Austria, and Experimental and Clinical Pharmacopsychology, Department of Psychiatry, Psychotherapy and Psychosomatics, University Hospital of Psychiatry Zurich, 8032 Zurich, Switzerland., Simmler LD; Psychopharmacology Research Group, Division of Clinical Pharmacology and Toxicology, Department of Biomedicine and Department of Internal Medicine, University Hospital and University of Basel, 4031 Basel, Switzerland, Laboratory for Biological and Personality Psychology, Department of Psychology, University of Freiburg, 79085 Freiburg, Germany, Department of Psychology, Behavioral and Clinical Neuroscience Institute, University of Cambridge, CB21TN Cambridge, UK, Social, Cognitive and Affective Neuroscience Unit, Faculty of Psychology, University of Vienna, 1010 Vienna, Austria, and Experimental and Clinical Pharmacopsychology, Department of Psychiatry, Psychotherapy and Psychosomatics, University Hospital of Psychiatry Zurich, 8032 Zurich, Switzerland., Domes G; Psychopharmacology Research Group, Division of Clinical Pharmacology and Toxicology, Department of Biomedicine and Department of Internal Medicine, University Hospital and University of Basel, 4031 Basel, Switzerland, Laboratory for Biological and Personality Psychology, Department of Psychology, University of Freiburg, 79085 Freiburg, Germany, Department of Psychology, Behavioral and Clinical Neuroscience Institute, University of Cambridge, CB21TN Cambridge, UK, Social, Cognitive and Affective Neuroscience Unit, Faculty of Psychology, University of Vienna, 1010 Vienna, Austria, and Experimental and Clinical Pharmacopsychology, Department of Psychiatry, Psychotherapy and Psychosomatics, University Hospital of Psychiatry Zurich, 8032 Zurich, Switzerland., Heinrichs M; Psychopharmacology Research Group, Division of Clinical Pharmacology and Toxicology, Department of Biomedicine and Department of Internal Medicine, University Hospital and University of Basel, 4031 Basel, Switzerland, Laboratory for Biological and Personality Psychology, Department of Psychology, University of Freiburg, 79085 Freiburg, Germany, Department of Psychology, Behavioral and Clinical Neuroscience Institute, University of Cambridge, CB21TN Cambridge, UK, Social, Cognitive and Affective Neuroscience Unit, Faculty of Psychology, University of Vienna, 1010 Vienna, Austria, and Experimental and Clinical Pharmacopsychology, Department of Psychiatry, Psychotherapy and Psychosomatics, University Hospital of Psychiatry Zurich, 8032 Zurich, Switzerland., Eisenegger C; Psychopharmacology Research Group, Division of Clinical Pharmacology and Toxicology, Department of Biomedicine and Department of Internal Medicine, University Hospital and University of Basel, 4031 Basel, Switzerland, Laboratory for Biological and Personality Psychology, Department of Psychology, University of Freiburg, 79085 Freiburg, Germany, Department of Psychology, Behavioral and Clinical Neuroscience Institute, University of Cambridge, CB21TN Cambridge, UK, Social, Cognitive and Affective Neuroscience Unit, Faculty of Psychology, University of Vienna, 1010 Vienna, Austria, and Experimental and Clinical Pharmacopsychology, Department of Psychiatry, Psychotherapy and Psychosomatics, University Hospital of Psychiatry Zurich, 8032 Zurich, Switzerland Psychopharmacology Research Group, Division of Clinical Pharmacology and Toxicology, Department of Biomedicine and Department of Internal Medicine, University Hospital and University of Basel, 4031 Basel, Switzerland, Laboratory for Biological and Personality Psychology, Department of Psychology, University of Freiburg, 79085 Freiburg, Germany, Department of Psychology, Behavioral and Clinical Neuroscience Institute, University of Cambridge, CB21TN Cambridge, UK, Social, Cognitive and Affective Neuroscience Unit, Faculty of Psychology, University of Vienna, 1010 Vienna, Austria, and Experimental and Clinical Pharmacopsychology, Department of Psychiatry, Psychotherapy and Psychosomatics, University Hospital of Psychiatry Zurich, 8032 Zurich, Switzerland., Preller KH; Psychopharmacology Research Group, Division of Clinical Pharmacology and Toxicology, Department of Biomedicine and Department of Internal Medicine, University Hospital and University of Basel, 4031 Basel, Switzerland, Laboratory for Biological and Personality Psychology, Department of Psychology, University of Freiburg, 79085 Freiburg, Germany, Department of Psychology, Behavioral and Clinical Neuroscience Institute, University of Cambridge, CB21TN Cambridge, UK, Social, Cognitive and Affective Neuroscience Unit, Faculty of Psychology, University of Vienna, 1010 Vienna, Austria, and Experimental and Clinical Pharmacopsychology, Department of Psychiatry, Psychotherapy and Psychosomatics, University Hospital of Psychiatry Zurich, 8032 Zurich, Switzerland., Quednow BB; Psychopharmacology Research Group, Division of Clinical Pharmacology and Toxicology, Department of Biomedicine and Department of Internal Medicine, University Hospital and University of Basel, 4031 Basel, Switzerland, Laboratory for Biological and Personality Psychology, Department of Psychology, University of Freiburg, 79085 Freiburg, Germany, Department of Psychology, Behavioral and Clinical Neuroscience Institute, University of Cambridge, CB21TN Cambridge, UK, Social, Cognitive and Affective Neuroscience Unit, Faculty of Psychology, University of Vienna, 1010 Vienna, Austria, and Experimental and Clinical Pharmacopsychology, Department of Psychiatry, Psychotherapy and Psychosomatics, University Hospital of Psychiatry Zurich, 8032 Zurich, Switzerland., Liechti ME; Psychopharmacology Research Group, Division of Clinical Pharmacology and Toxicology, Department of Biomedicine and Department of Internal Medicine, University Hospital and University of Basel, 4031 Basel, Switzerland, Laboratory for Biological and Personality Psychology, Department of Psychology, University of Freiburg, 79085 Freiburg, Germany, Department of Psychology, Behavioral and Clinical Neuroscience Institute, University of Cambridge, CB21TN Cambridge, UK, Social, Cognitive and Affective Neuroscience Unit, Faculty of Psychology, University of Vienna, 1010 Vienna, Austria, and Experimental and Clinical Pharmacopsychology, Department of Psychiatry, Psychotherapy and Psychosomatics, University Hospital of Psychiatry Zurich, 8032 Zurich, Switzerland matthias.liechti@usb.ch.

Publikováno v: Social cognitive and affective neuroscience [Soc Cogn Affect Neurosci] 2014 Nov; Vol. 9 (11), pp. 1645-52. Date of Electronic Publication: 2013 Oct 04.